ATE466029T1 - Verfahren zur modulation der proliferation von schilddrüsenkrebszellen - Google Patents

Verfahren zur modulation der proliferation von schilddrüsenkrebszellen

Info

Publication number
ATE466029T1
ATE466029T1 AT07006462T AT07006462T ATE466029T1 AT E466029 T1 ATE466029 T1 AT E466029T1 AT 07006462 T AT07006462 T AT 07006462T AT 07006462 T AT07006462 T AT 07006462T AT E466029 T1 ATE466029 T1 AT E466029T1
Authority
AT
Austria
Prior art keywords
cys
cancer cell
cell proliferation
thyroid cancer
cyclo
Prior art date
Application number
AT07006462T
Other languages
English (en)
Inventor
Uberti Ettore Ciro Degli
Michael Dewitt Culler
Maria Chiara Zatelli
David H Coy
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Application granted granted Critical
Publication of ATE466029T1 publication Critical patent/ATE466029T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT07006462T 2001-03-06 2002-03-06 Verfahren zur modulation der proliferation von schilddrüsenkrebszellen ATE466029T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27369901P 2001-03-06 2001-03-06

Publications (1)

Publication Number Publication Date
ATE466029T1 true ATE466029T1 (de) 2010-05-15

Family

ID=23045039

Family Applications (3)

Application Number Title Priority Date Filing Date
AT02725077T ATE362489T1 (de) 2001-03-06 2002-03-06 Verfahren zur modulierung der proliferation von medullären schilddrüsen-karzinomzellen
AT07006462T ATE466029T1 (de) 2001-03-06 2002-03-06 Verfahren zur modulation der proliferation von schilddrüsenkrebszellen
AT07006463T ATE430162T1 (de) 2001-03-06 2002-03-06 Verfahren zur modulation der proliferation von schilddrüsenkrebszellen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02725077T ATE362489T1 (de) 2001-03-06 2002-03-06 Verfahren zur modulierung der proliferation von medullären schilddrüsen-karzinomzellen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT07006463T ATE430162T1 (de) 2001-03-06 2002-03-06 Verfahren zur modulation der proliferation von schilddrüsenkrebszellen

Country Status (10)

Country Link
US (3) US20050124549A1 (de)
EP (3) EP1390406B1 (de)
JP (2) JP4294959B2 (de)
AT (3) ATE362489T1 (de)
CA (2) CA2743731C (de)
DE (3) DE60236225D1 (de)
ES (3) ES2328077T3 (de)
NO (1) NO20033881L (de)
RU (3) RU2352578C2 (de)
WO (1) WO2002070555A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262229B1 (en) * 1996-12-04 2001-07-17 Biomeasure Incorporated Somatostatin antagonists
RU2352578C2 (ru) * 2001-03-06 2009-04-20 Иль Консорцио Феррара Ричерке Способ модуляции пролиферации клеток медуллярной карциномы щитовидной железы
RU2263678C2 (ru) * 2001-03-08 2005-11-10 Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд Антагонисты соматостатина
EP1522311A1 (de) * 2003-10-10 2005-04-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verwendung von Somatostatin oder seine Derivate zur Herstellung eines Medikamentes zur Regulierung der Ovarialfollikelnreserve bei der nicht menopausierte Frau
GB0602639D0 (en) * 2006-02-09 2006-03-22 Novartis Ag Organic compounds
EP2003967B1 (de) 2006-03-23 2011-09-07 Ipsen Pharma Verwendung von somatostatin-agonisten zur behandlung von medullärem schilddrüsenkarzinom
EP2835136A1 (de) 2013-08-07 2015-02-11 PregLem S.A. Somatostatin Receptor Modulator zur Unfruchtbarkeitsbehandlung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661472A (en) * 1985-05-09 1987-04-28 The Salk Institute For Biological Studies GnRH antagonists IX
SK15096A3 (en) 1993-08-09 1996-07-03 Biomeasure Inc Therapeutic peptide derivatives and a method of their application
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
ATE234113T1 (de) 1997-05-01 2003-03-15 Cedars Sinai Medical Center Verfahren zur behandlung von hyperprolaktinämia und prolaktinomen
US5972893A (en) * 1997-05-06 1999-10-26 Cedars-Sinai Medical Center Method of treating hyperprolactinemia and prolactinomas
US6180082B1 (en) * 1997-11-24 2001-01-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method to enhance tissue accumulation of radiolabeled compounds
AU749403B2 (en) 1997-11-24 2002-06-27 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College, The Method to enhance tissue accumulation of radiolabeled compounds
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
MXPA01000969A (es) 1998-07-30 2003-04-07 Scient Sas Soc De Conseils De Metodo de uso de un analogo de somatostatina.
HUP0201696A3 (en) * 1999-06-25 2002-10-28 Sod Conseils Rech Applic Cyclic peptides, pharmaceutical compositions comprising thereof and their use
RU2352578C2 (ru) * 2001-03-06 2009-04-20 Иль Консорцио Феррара Ричерке Способ модуляции пролиферации клеток медуллярной карциномы щитовидной железы

Also Published As

Publication number Publication date
WO2002070555A2 (en) 2002-09-12
EP1390406B1 (de) 2007-05-16
CA2440214C (en) 2012-05-22
RU2317824C2 (ru) 2008-02-27
US20050124549A1 (en) 2005-06-09
RU2003129515A (ru) 2005-03-27
DE60220157D1 (de) 2007-06-28
US20070259811A1 (en) 2007-11-08
DE60220157T2 (de) 2008-01-17
ES2345280T3 (es) 2010-09-20
NO20033881D0 (no) 2003-09-02
WO2002070555A3 (en) 2003-12-04
CA2743731C (en) 2014-05-06
US20110183416A1 (en) 2011-07-28
RU2005132456A (ru) 2007-04-27
NO20033881L (no) 2003-10-10
US9220760B2 (en) 2015-12-29
CA2440214A1 (en) 2002-09-12
RU2275934C2 (ru) 2006-05-10
JP2005506289A (ja) 2005-03-03
EP1390406A2 (de) 2004-02-25
ATE430162T1 (de) 2009-05-15
DE60232203D1 (de) 2009-06-10
EP1897889A3 (de) 2008-03-26
EP1813625A1 (de) 2007-08-01
ATE362489T1 (de) 2007-06-15
EP1897889A2 (de) 2008-03-12
ES2328077T3 (es) 2009-11-06
EP1897889B1 (de) 2010-04-28
EP1813625B1 (de) 2009-04-29
ES2284859T3 (es) 2007-11-16
JP4828438B2 (ja) 2011-11-30
JP2007145854A (ja) 2007-06-14
RU2352578C2 (ru) 2009-04-20
CA2743731A1 (en) 2002-09-12
DE60236225D1 (de) 2010-06-10
RU2007111864A (ru) 2008-10-10
JP4294959B2 (ja) 2009-07-15

Similar Documents

Publication Publication Date Title
CY1109256T1 (el) Κυανο-υποκατεστημενα παραγωγα ολεανολικου οξεος ως αναστολεις παραγωγης νο
DE69128516D1 (de) Neue Mercaptoacetylamid-Derivate zur Verwendung als Enkephalinase- und ACE-Hemmer
BR9804214A (pt) Compostos.
DE69227571D1 (de) Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivität und zur behandlung von tumoren
ATE220317T1 (de) Verwendung von betainen als antitranspirantien
EA200201071A1 (ru) Циклопентилзамещенные производные глутарамида в качестве ингибиторов нейтральной эндопептидазы
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
GB9715030D0 (en) Metalloproteinase inhibitors
EA199800109A1 (ru) Производные азетидинона для лечения атеросклероза
ATE466029T1 (de) Verfahren zur modulation der proliferation von schilddrüsenkrebszellen
ATE191317T1 (de) Verwendung von beta-aminopropionsäure-derivaten als fungizide
EP0924199A4 (de)
DK1272457T3 (da) Forbindelser til modulation af celleproliferation
DE59307409D1 (de) Verfahren zur Herstellung von (3R,5S)6-Hydroxy-3,5-0-isopropyliden-3,5-dihydroxy-hexansäure-tert.-butylester
ES2179254T3 (es) 1-poliarilpirazoles plaguicidas.
DE60125378D1 (de) Verfahren zur herstellung von 2-aminomethyl-halogen-pyridinen
ATE211719T1 (de) Korrosionsinhibitoren enthaltender injektionszement
ATE339475T1 (de) Verfahren zur hydrophilierung von fluoreszierenden markierstoffen
DE69431824D1 (de) Verfahren zur Herstellung von Schwefelhaltigen Imidazolderivaten und erhaltene Zwischenprodukte
EA199800242A1 (ru) Амиды карбамоилкарбоновой кислоты
FI963168A0 (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia indaani-2-merkaptoasetyyliamiddisulfidijohdannaisia
PT1156999E (pt) Metodo para a preparacao de um beta-aminoester quiral
HK1023335A1 (en) Acetoacetarylamides.
ATE265854T1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
ATE135352T1 (de) 3-keto-hmg-coa reduktase-inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties